Parallax Volatility Advisers
ABEO icon

Parallax Volatility Advisers’s Abeona Therapeutics ABEO Stock Holding History

Parallax Volatility Advisers’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-171
Closed -$68K – 2132
2017
Q4 		$68K Buy
+171
New +$70.7K ﹤0.01% 3034

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Parallax Volatility Advisers's ABEO Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Abeona Therapeutics (ABEO) in Q1 2018, closing a stake of 171 shares — an estimated $68K sold.

Parallax Volatility Advisers first reported a position in ABEO in Q4 2017 and held it in 1 quarter. The position peaked at $68K in Q4 2017. 88 funds tracked by Wall St. Rank hold ABEO as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Abeona Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 171 Abeona Therapeutics shares in Q1 2018, an estimated $68K.
  • Parallax Volatility Advisers first reported a position in Abeona Therapeutics in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Abeona Therapeutics position peaked at $68K in Q4 2017.
  • 88 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.